Meisl Georg
WaveBreak Therapeutics Ltd., Chemistry of Health, Lensfield Road, Cambridge CB2 1EW, United Kingdom.
Biophys Rev (Melville). 2024 Mar 20;5(1):011303. doi: 10.1063/5.0180899. eCollection 2024 Mar.
The formation of protein aggregates in the brain is a central aspect of the pathology of many neurodegenerative diseases. This self-assembly of specific proteins into filamentous aggregates, or fibrils, is a fundamental biophysical process that can easily be reproduced in the test tube. However, it has been difficult to obtain a clear picture of how the biophysical insights thus obtained can be applied to the complex, multi-factorial diseases and what this means for therapeutic strategies. While new, disease-modifying therapies are now emerging, for the most devastating disorders, such as Alzheimer's and Parkinson's disease, they still fall well short of offering a cure, and few drug design approaches fully exploit the wealth of mechanistic insights that has been obtained in biophysical studies. Here, I attempt to provide a new perspective on the role of protein aggregation in disease, by phrasing the problem in terms of a system that, under constant energy consumption, attempts to maintain a healthy, aggregate-free state against the thermodynamic driving forces that inexorably push it toward pathological aggregation.
大脑中蛋白质聚集体的形成是许多神经退行性疾病病理学的核心方面。这种特定蛋白质自组装成丝状聚集体或原纤维是一个基本的生物物理过程,很容易在试管中重现。然而,要清楚了解如此获得的生物物理见解如何应用于复杂的多因素疾病以及这对治疗策略意味着什么一直很困难。虽然现在出现了新的疾病修饰疗法,但对于最具毁灭性的疾病,如阿尔茨海默病和帕金森病,它们仍远远无法提供治愈方法,而且很少有药物设计方法能充分利用生物物理研究中获得的丰富机制见解。在此,我试图通过将问题表述为一个系统,即在持续能量消耗的情况下,试图对抗无情地将其推向病理性聚集的热力学驱动力来维持健康、无聚集体状态,从而为蛋白质聚集在疾病中的作用提供一个新视角。